MicroPort CardioFlow Medtech (HKSE:02160) Accounts Payable & Accrued Expense : HK$133.9 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is MicroPort CardioFlow Medtech Accounts Payable & Accrued Expense?

MicroPort CardioFlow Medtech's quarterly accounts payable & accrued expense declined from Dec. 2022 (HK$99.3 Mil) to Jun. 2023 (HK$85.7 Mil) but then increased from Jun. 2023 (HK$85.7 Mil) to Dec. 2023 (HK$133.9 Mil).

MicroPort CardioFlow Medtech's annual accounts payable & accrued expense declined from Dec. 2021 (HK$130.6 Mil) to Dec. 2022 (HK$99.3 Mil) but then increased from Dec. 2022 (HK$99.3 Mil) to Dec. 2023 (HK$133.9 Mil).

MicroPort CardioFlow Medtech Accounts Payable & Accrued Expense Historical Data

The historical data trend for MicroPort CardioFlow Medtech's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort CardioFlow Medtech Accounts Payable & Accrued Expense Chart

MicroPort CardioFlow Medtech Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

25.39

84.15

130.60

99.33

133.89

MicroPort CardioFlow Medtech Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial					130.60	107.07	99.33	85.69	133.89

MicroPort CardioFlow Medtech Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

MicroPort CardioFlow Medtech (HKSE:02160) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort CardioFlow Medtech Corp (HKSE:02160) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

72X:Germany

Address

No. 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai, CHN, 201203

Website

https://www.cardioflowmedtech.com

MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of three products VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China.

Executives

China Renaissance Holdings Limited	2201 Interest of corporation controlled by you
Hua Jie Tian Jin Yi Liao Tou Zi He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Shang Hai Hua Hao Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Tian Jin Hua Jie Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Tian Jin Hua Qing Qi Ye Guan Li Zi Xun You Xian Gong Si	2201 Interest of corporation controlled by you
Microport Scientific Corporation	2201 Interest of corporation controlled by you
Shanghai Microport Limited	2101 Beneficial owner
China International Capital Corporation Limited	2201 Interest of corporation controlled by you
Cicc Capital Management Co., Ltd.	2201 Interest of corporation controlled by you
Cicc Kangrui I (ningbo) Equity Investment Limited Partners (limited Partnership)	2101 Beneficial owner
Cicc Kangzhi (ningbo) Equity Investment Management Co., Ltd.	2201 Interest of corporation controlled by you

MicroPort CardioFlow Medtech (HKSE:02160) Headlines

No Headlines